Taken together, these data indicate frequent and concomitant up-regulation of PPARβ/δ, VEGF and components of the Cox-2/prostaglandin synthetic pathway in a subset of NSCLC and provide support to the hypothesis that activation of these pathways may play a role in lung carcinogenesis. The gene discussed is PTGS2; the disease is non-small cell lung carcinoma.